155 results
424B2
GRN
Barclays Bank PLC
29 Mar 24
Prospectus for primary offering
1:41pm
therapy. The company offers educational and training materials. Novo Nordisk markets worldwide.
Information filed by Novo Nordisk A with the SEC
424B2
GRN
Barclays Bank PLC
26 Mar 24
Prospectus for primary offering
4:23pm
, growth disorders, and hormone replacement therapy. The company offers educational and training materials. Novo Nordisk markets worldwide.
Information
424B2
GRN
Barclays Bank PLC
25 Mar 24
Prospectus for primary offering
10:00am
such as haemostatis management, growth disorders, and hormone replacement therapy. The company offers educational and training materials. Novo Nordisk markets
424B2
GRN
Barclays Bank PLC
15 Mar 24
Prospectus for primary offering
5:53pm
educational and training materials. Novo Nordisk markets worldwide.
Information filed by Novo Nordisk A with the SEC under the Exchange Act can
6-K
EX-99.1
GRN
Barclays Bank PLC
27 Jul 23
Current report (foreign)
10:45am
expense over total income. Compensation represents total staff costs less non-compensation items consisting of outsourcing, staff training, redundancy
6-K
EX-99.1
2um 3g567jg
28 Jul 22
Current report (foreign)
11:11am
20-F/A
raes v52vv0wyy3
23 May 22
Annual report (foreign) (amended)
12:16pm
6-K
EX-99.1
5ej wg4we
28 Apr 22
Current report (foreign)
1:21pm
6-K
EX-99.1
hih0ag8gi42moz 4cse
28 Jul 21
Current report (foreign)
11:40am
6-K
x9t9ky0
18 Feb 21
Annual Financial Report
12:56pm
6-K
EX-99.1
v5lg1txdtpoisb6ze9ds
29 Jul 20
Current report (foreign)
9:55am
6-K
15715xjnq6pnjzcecm
13 Feb 20
Annual Financial Report
2:52pm
6-K
EX-99.1
4c85g f4w
1 Aug 19
Current report (foreign)
9:08am
6-K
EX-99.1
0lnc5ajms7
2 Aug 18
Current report (foreign)
12:27pm